Hindcon Chemicals Ltd IPO subscribes 132 times

The initial public offer (IPO) of Hindcon Chemicals Ltd, engaged in manufacturing wide range of chemical products, received overwhelming response on the last day procuring subscription amount of over Rs 1022 crore as the issue overall subscribed 132.29 times. The HNI and Retail portion subscribed 154.85 and 124.18 times respectively. The public issue which was open for subscription from 26 February to 28 February 2018 at the NSE Emerge platform raised 7.73 Cr through offering 27, 60,000 Equity Shares of face value of Rs. 10 each for cash at price of Rs. 28 per Equity Share. The net proceeds from the IPO will be utilized for meeting working capital requirements, general corporate and issue expenses.

Hindcon Chemicals, incorporated in 1998, has been in the business of construction chemicals for the last 20 years. The Company has over 100 products in its portfolio with main foray into sodium silicate, waterproofing additives, plasticizers etc. The Company has its manufacturing facility located in Howrah which has an installed capacity of 30,000 MT per year. Company’s key product portfolio includes Protective waterproofing coatings, Sodium Silicates, Concrete & mortar admixtures, Epoxy grouts & mortars, Waterproofing compounds, Shot crete aids, Remover cleaning compounds, Sealants, Tile adhesives, among others.

The total revenue of the Company for the half year ended on September 30, 2017 stood at Rs. 1812.55 lakhs, for F.Y. 2016-17 – Rs. 3424.97 lakhs, for F.Y. 2015-16 - Rs. 3345.37 lakhs, and for F.Y. 2014-15 Rs. 3496.44 lakhs. Further, the Company’s Profit after tax for the half year ended on September 30, 2017 stood at Rs. 218.87 lakhs, for F.Y. 2016-17 – Rs. 205.95 lakhs, for F.Y. 2015-16 - Rs. 86.20 lakhs and for F.Y. 2014-15 Rs. 34.48 lakhs.

Comments

Smallcase Platform: 2025 Wealth Creation Strategies to Achieve Your Investment Goals

By Dr. Vikas Gupta, CEO and Chief Investment Strategist, OmniScience Capital In the intricate world of finance, wealth creation is a universal aspiration among investors, though few truly attain it. With a plethora of investment products, philosophies, and strategies available, the challenge is identifying an approach that not only offers returns but also minimizes risk. At OmniScience Capital, we believe the key to successful wealth creation lies in a scientific and disciplined investment strategy. Our unique offerings, rooted in the principles of Scientific Investing, are designed to help you achieve your financial goals with confidence. Pioneering Global Investing and Outperforming on Smallcase Platform OmniScience Capital, a global investment management firm specializing in global and Indian equities, is a pioneer in global investing and growth vectors such as Defense and Digital Transformation. Our strategies have consistently identified and capitalized on growth vectors tha...

Country Delight Launches NMR-Tested Honey: The Gold Standard of Purity

Country Delight continues strengthening its promise of delivering the best purity and quality by launching 100% Pure Farm Honey (NMR Tested) Country Delight, a trusted name in premium and natural essentials, has announced the launch of 100% Pure Farm Honey (NMR Tested). Country Delight’s Farm Honey is Nuclear Magnetic Resonance (NMR) tested by a certified lab in Germany, making it one of the most authentic and reliable kitchen ingredients available to Indian homes. It also undergoes rigorous testing on 36 quality parameters as per FSSAI standards, including physicochemical, antibiotic and microbial, to rule out the presence of added sugars. Honey is not just a natural sweetener; it is increasingly valued for its functional benefits. With Country Delight's NMR-tested honey, consumers can enjoy a product that supports wellness through its natural composition, which is rich in antioxidants and phytonutrients and offers advantages over refined sugars. Adulteration with cheaper ...

Prachay Capital’s Public Issue of Secured NCDs Fully Subscribed at 113.36%

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has successfully closed its public issue of Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) at 113.36% subscription, according to exchange data. The issue, which opened on February 28, 2025, on the Bombay Stock Exchange (BSE), aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. With a BSE listing, this issue was open for subscription to retail investors, high-net-worth individuals (HNIs), institutional investors, and corporates. The maiden NCDs issue is scheduled to list on 24 March 2025. Rated BBB-/Stable by CRISIL, these NCDs offer investors a 13% per annum return with monthly interest payouts, making them an attractive fixed-income opportunity. The proceeds will be deployed as per the company’s stated fund allocation plan. Fund Utilization: Minimum 75% for the purpose of onward lending, investments in current and...

Wealth Growth Path

Search This Blog